These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 17685886)
1. Novel uses for risperidone: focus on depressive, anxiety and behavioral disorders. Ravindran AV; Bradbury C; McKay M; da Silva TL Expert Opin Pharmacother; 2007 Aug; 8(11):1693-710. PubMed ID: 17685886 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. Maher AR; Maglione M; Bagley S; Suttorp M; Hu JH; Ewing B; Wang Z; Timmer M; Sultzer D; Shekelle PG JAMA; 2011 Sep; 306(12):1359-69. PubMed ID: 21954480 [TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotics for disruptive behaviour disorders in children and youths. Loy JH; Merry SN; Hetrick SE; Stasiak K Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123 [TBL] [Abstract][Full Text] [Related]
4. Risperidone: review of its therapeutic utility in depression. Myers JE; Thase ME Psychopharmacol Bull; 2001; 35(4):109-29. PubMed ID: 12397861 [TBL] [Abstract][Full Text] [Related]
5. Does risperidone have a place in the treatment of nonschizophrenic patients? Schweitzer I Int Clin Psychopharmacol; 2001 Jan; 16(1):1-19. PubMed ID: 11195255 [TBL] [Abstract][Full Text] [Related]
6. Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an update. DeVane CL; Mintzer J Psychopharmacol Bull; 2003; 37(4):116-32. PubMed ID: 15131522 [TBL] [Abstract][Full Text] [Related]
7. Quetiapine: novel uses in the treatment of depressive and anxiety disorders. Ravindran AV; Al-Subaie A; Abraham G Expert Opin Investig Drugs; 2010 Oct; 19(10):1187-204. PubMed ID: 20795889 [TBL] [Abstract][Full Text] [Related]
9. Use of atypical antipsychotics: observations from clinical practice. Spier SA J Clin Psychiatry; 2006 Mar; 67(3):490-1. PubMed ID: 16649838 [No Abstract] [Full Text] [Related]
10. A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders. Simeon J; Milin R; Walker S Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):267-75. PubMed ID: 11817503 [TBL] [Abstract][Full Text] [Related]
11. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone. Aman MG; Gharabawi GM; J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046 [TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373 [TBL] [Abstract][Full Text] [Related]
13. An open-label trial of risperidone augmentation for refractory anxiety disorders. Simon NM; Hoge EA; Fischmann D; Worthington JJ; Christian KM; Kinrys G; Pollack MH J Clin Psychiatry; 2006 Mar; 67(3):381-5. PubMed ID: 16649823 [TBL] [Abstract][Full Text] [Related]